Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system

European Journal of Dermatology

Volumn 14, Issue 2, 2004, Pages 107-113

  Augustin, Matthias ^a   Lange, Sabine ^a   Wenninger, Kerstin ^a   Seidenglanz, Karin ^a   Amon, Ulrich ^b   Zschocke, Ina ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Dermatological Treatm Ctr H   (Germany)

Author keywords

Atopic dermatitis; Health related quality of life; Psoriasis; Questionnaire; Skin diseases

Indexed keywords

ACCURACY; ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PATIENT SATISFACTION; PHYSICAL DISABILITY; PSORIASIS; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SKIN DISEASE; SOCIAL LIFE; VALIDATION PROCESS;

ADULT; DERMATITIS, ATOPIC; HUMANS; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 1942537029     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Augustin M, Dieterle W, Zschocke I, Brill C, Trefzer D, Peschen M, Vanscheidt W. Development and validation of a disease specific questionnaire on the quality of life of patients with chronic venous insufficiency. VASA 1997; 26: 291-301.
2. Augustin M, Zschocke I, Seidenglanz K, Lange S, Schiffler A, Amon U. Validation and clinical results of the FLQA-d, a quality of life questionnaire for patients with chronic skin diseases. Dermatol Psychosom 2000; 1: 12-7.
3. Chren AAM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality of life measure for patients with skin disease: reliability, validity and respansiveness. J Invest Dermatol 1996; 107: 707-13.
4. Finlay AY, Kahn GK. Dermatology Life Quality Index [DLQI): a simple practical measure far routine clinical use. Clin Exp Dermatol 1994; 9: 210-6.
5. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure af disease activity. Acta Derm Venereol 2000; 80: 430-4.
6. Zachariae R, Zachariae H, Blomqvist K, Davindsson S, Molin L, Mørk C, Sigurgeirsson B. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002; 146: 1006-16.
7. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997; 136: 305-14.
8. Sackett DL, Chambers LW, MacPherson AS, Goldsmith CH, McAuley RG. The development and application of indices of health: general methods and summary of results. Am J Public Health 1977; 67: 423-8.
9. Augustin M, Amon U, Bullinger M, Gieler U: Recommendations for the assessment of quality of life in dermatology. Dermatol Psychosom 2000; 1: 84-7.
10. Augustin M. Erfassung von Lebensqualität in dermatologischen Studien. Leitlinie der Subkommission "Pharmako-Ökanomie und Lebensqualität" (Recording of quality of life in dermatological studies. Guidelines or the subcommission "Pharmacoeconomics and quality of life"). Hautarzt 2001; 52: 697-700.
11. Frederiksson T, Pettersson U. Severe Psoriasis - Oral Therapy with a new Retinoid. Dermatologica 1978; 157: 238-44.
12. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: The SCORAD Index. Dermatol 1993; 186: 23-31.
13. Bullinger M, Kirchberger I, von Steinbüchel N. Der Fragebogen Alltagsleben - ein Verfahren zur Erfassung der gesundheitsbezogenen Lebensqualität. (The Questionnaire on Everyday Living - an instrument for the assessment of health-related quality of life). Z Med Psychol 1993; 3: 121-31.
14. Schepank H. Epidemiologie psychogener Erkrankungen - Ein Beitrag zur Grundlagenforschung aus einer Feldstudie (Epidemiology af psychagenic diseases - A research contribution from a field study). Z Psychosom Med 1982; 28: 104-25.
15. Fritzsche K, Ott J, Zschacke I, Scheib P, Burger T, Augustin M. Psychosomatic liaisan service in dermatology. Need for psychotherapeutic interventions and their realization. Dermatology 2001; 203: 27-31.
16. Strittmatter G, Mawick R, Tilkorn M. Psychosozialer Betreuungsbedarf bei Gesichts- und Hautturmorpatienten. (The need for psychosocial intervention in facial and skin tumor patients). Psychother Psychosam med Psychol 1998; 48: 349-57.
17. Strittmatter G, Tilkorn M, Mawick R. Screening of patients for psychosocial risk by the doctor - a contribution to assurance of quality of treatment integrated intervention. Psycho-Onkology 1998; 7(Suppl.): 142.
18. Jacobson NS, Roberts LJ, Berns SB, McGlinchey JB. Methods for defining and determining the clinical significance of treatment effects: Description, application and alternatives. J Consult Clin Psychol 1999; 67: 300-7.